Cargando…

Radiotherapy for prostate cancer and sexual health

Sexual dysfunction is very common after treatment of prostate cancer. Radiation therapy together with radical prostatectomy is the most effective treatment for localized disease. Percentages of erectile dysfunction (ED) reported in prospective studies after external-beam radiotherapy (RT) vary from...

Descripción completa

Detalles Bibliográficos
Autor principal:	Incrocci, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708125/ https://www.ncbi.nlm.nih.gov/pubmed/26813740 http://dx.doi.org/10.3978/j.issn.2223-4683.2014.12.08

Ejemplares similares

AB007. Testosterone and radiotherapy for prostate cancer
por: Incrocci, Luca
Publicado: (2015)

Sexual function and male cancer
por: Incrocci, Luca
Publicado: (2013)

Is there a sexual life after treatment of cancer?
por: Incrocci, Luca
Publicado: (2015)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: Swanson, William, et al.
Publicado: (2021)

Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy
por: Irabor, Omoruyi Credit, et al.
Publicado: (2020)

Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis
por: Sinzabakira, F., et al.
Publicado: (2023)

Association between incidental dose outside the prostate and tumor control after modern image-guided radiotherapy
por: Witte, Marnix, et al.
Publicado: (2021)

Recommended patient information sheet on the impact of haematopoietic cell transplantation on sexual functioning and sexuality
por: Eeltink, Corien M, et al.
Publicado: (2019)

Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
por: Incrocci, Luca
Publicado: (2014)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Patterns of Care of Cancers and Radiotherapy in Ethiopia
por: Rick, Tara, et al.
Publicado: (2019)

Automated Radiotherapy Planning for Patient-Specific Exploration of the Trade-Off Between Tumor Dose Coverage and Predicted Radiation-Induced Toxicity—A Proof of Principle Study for Prostate Cancer
por: Bijman, Rik, et al.
Publicado: (2020)

Effects of surgery versus radiotherapy in patients with localized prostate cancer in terms of urinary, bowel, and sexual domains
por: Yu, Chao, et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Prostate Cancer and Sexual Function
por: Hyun, Jae Saog
Publicado: (2012)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

Cost effectiveness of prostate cancer radiotherapy
por: Konski, Andre
Publicado: (2018)

Intensity-modulated radiotherapy for prostate cancer
por: Fischer-Valuck, Ben W., et al.
Publicado: (2018)

Image-guided radiotherapy for prostate cancer
por: Dang, Audrey, et al.
Publicado: (2018)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
por: Jahreiß, Marie-Christina, et al.
Publicado: (2021)

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

The role of postoperative radiotherapy in prostate cancer patients
por: Zarzycka, Małgorzata, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)

RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

Radiotherapy Practice for Treatment of Bone Metastasis in Ethiopia
por: Rick, Tara J., et al.
Publicado: (2020)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Contemporary role of postoperative radiotherapy for prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Pelvic radiotherapy and sexual function in women
por: Jensen, Pernille Tine, et al.
Publicado: (2015)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

The role of radiotherapy in localised and locally advanced prostate cancer
por: Bolla, Michel, et al.
Publicado: (2019)

Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)

PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer
por: Meher, Niranjan, et al.
Publicado: (2023)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2023)

Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors
por: Eeltink, Corien M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gfijevtphhrhn4p34pjn1kmqp6